SMTI Stock Earnings Sanara MedTech Misses EPS, Beats Revenue for Q1 2024
SMTI Stock | USD 34.00 1.36 4.17% |
Under 70 percent of all Sanara Medtech's traders are curious in acquiring. The analysis of overall sentiment of trading Sanara Medtech stock suggests that a large number of investors are confidant at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
Sanara |
SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Read at investorplace.com
Sanara Medtech Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Sanara Medtech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sanara Medtech Fundamental Analysis
We analyze Sanara Medtech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanara Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanara Medtech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Sanara Medtech is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Sanara Medtech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sanara Medtech stock to make a market-neutral strategy. Peer analysis of Sanara Medtech could also be used in its relative valuation, which is a method of valuing Sanara Medtech by comparing valuation metrics with similar companies.
Peers
Sanara Medtech Related Equities
MLSS | Milestone Scientific | 5.36 | ||||
NVST | Envista Holdings | 3.63 | ||||
MHUA | Meihua International | 3.23 | ||||
INFU | InfuSystems Holdings | 3.13 | ||||
POCI | Precision Optics, | 2.86 | ||||
ATR | AptarGroup | 2.40 | ||||
HAE | Haemonetics | 2.38 | ||||
KRMD | Repro Med | 1.22 | ||||
MMSI | Merit Medical | 0.81 | ||||
LMAT | LeMaitre Vascular | 0.60 | ||||
UTMD | Utah Medical | 0.27 | ||||
PDEX | Pro Dex | 0.07 | ||||
DXR | Daxor | 3.29 | ||||
ANGO | AngioDynamics | 3.94 |
Complementary Tools for Sanara Stock analysis
When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |